Results 121 to 130 of about 533,192 (191)

High-performance oxygen reduction electrocatalysis enabled by Ni_corePd_shell nanoparticles immobilized on MoS₂ nanosheets.

Nanoscale
Minadakis MP, Sato Y, Canton-Vitoria R, Suenaga K, Tagmatarchis N.   +4 more
europepmc   +1 more source

A New Era of Salvage-Line Treatment for Metastatic Colorectal Cancer: The Role and Clinical Significance of Circulating Tumor DNA. [PDF]

Biomolecules
Toyokawa E, Ooki A, Shinozaki E, Yoshikawa K, Suzuki K, Shiozawa M, Maeda S, Yamaguchi K, Osumi H.   +8 more
europepmc   +1 more source

Zanubrutinib-based regimen as the salvage or bridging treatment of CART therapy in relapsed or refractory, non-germinal center B-cell-like diffuse large B-cell lymphoma: a retrospective multicenter cohort study. [PDF]

Front Immunol
Lu Y, Ye S, Zhou L, Yuan X, Li P, Qian W, Liang A.   +6 more
europepmc   +1 more source

Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies. [PDF]

Cancer
Kim TM, Williamson SK, Papadopoulos KP, Hamid O, Dy GK, McDermott R, Birnbaum A, Kaczmar JM, Lakhani N, Rischin D, Sarker D, Dowlati A, Zhu XH, Malhotra J, Pouliot JF, Mani J, Brennan L, Fang F, Chen S, Salvati M, Lowy I, Khaled A, Lewis KD, Kroog G, Fury MG, Cho BC.   +25 more
europepmc   +1 more source

Modulation of the Spin State of Atomic Fe-N₄ Sites with Interlayer-Adjacent Ir-N₄ for Superior ORR Activity. [PDF]

Nanomicro Lett
Tan Y, Li A, Wang Y, Jiang X, Cheng Y, Chao D, Zhang Y, Cheng C.   +7 more
europepmc   +1 more source

Clinical application and optimization strategies for antibody-drug conjugates in solid tumors. [PDF]

J Int Med Res
Qu J, Zhao X, Zhang L, Cai W, Shen M, Liu X, Wei X, Fei F.   +7 more
europepmc   +1 more source

Interleukin-6 as a predictive biomarker of systemic progression and therapeutic target in cutaneous plasmacytosis. [PDF]

An Bras Dermatol
Hong YY, Chen PY, New HT, Cai SQ.
europepmc   +1 more source

Lorlatinib in advanced ALK-positive NSCLC after prior progression on ALK inhibitors: real-world experience in Russia. [PDF]

Explor Target Antitumor Ther
Orlov SV, Laktionov KK, Musaelyan AA, Reutova EV, Odintsova SV, Urtenova MA, Kuzmina VA, Tiurin VI, Lomakova AE, Imyanitov EN.   +9 more
europepmc   +1 more source

An investigation of electrocatalytic activity of the FeCe nanoparticle encapsulated carbon nanotube towards oxygen reduction reaction. [PDF]

RSC Adv
Halba D, Yadav L, Pakhira S.
europepmc   +1 more source

Safety and efficacy of CAR T-cell therapy in central nervous system lymphoma: a systematic review and meta-analysis. [PDF]

Front Oncol
Shawabkeh AE, Yasin J, Alsufi MI, AbuHashesh HS, Khraisat H, Muhanna Z, Salomon I, Salman SA, Obeid A, AlDaher L.   +9 more
europepmc   +1 more source